Akebia Therapeutics
Open
$1.39
Prev. Close
$1.39
High
$1.39
Low
$1.38
Market Snapshot
$360.9M
-67.5
-0.34
$160.18M
194
The company is headquartered in Cambridge, Massachusetts and currently employs 194 full-time employees. The company went IPO on 2014-03-20.
emptyResult
The company is headquartered in Cambridge, Massachusetts and currently employs 194 full-time employees. The company went IPO on 2014-03-20.
Recently from Cashu
Akebia Therapeutics: Positioned for Growth Amid Health Sector Innovations and Advancements
Akebia Therapeutics: Innovations Amid Growth in the Health Sector Akebia Therapeutics, a player in the biopharmaceutical industry, remains focused on developing and commercializing innovative therapie…
Akebia Therapeutics Faces Analyst Scrutiny Ahead of Key Quarterly Earnings Report
Akebia Therapeutics Prepares for Quarterly Earnings Amid Analyst Scrutiny As Akebia Therapeutics gears up to announce its quarterly earnings report on February 26, 2026, the focus is on the company’s…
Akebia Therapeutics: Earnings Report to Impact Future Growth in Chronic Kidney Disease Sector
Akebia Therapeutics' Strategic Focus on Chronic Kidney Disease: Implications for Future Growth Akebia Therapeutics is at a pivotal moment as it prepares to unveil its quarterly earnings report on Febr…
Akebia Therapeutics Prepares for Earnings Report Amid Chronic Kidney Disease Innovation Focus
Akebia Therapeutics' Focus on Chronic Kidney Disease Innovation Akebia Therapeutics (NASDAQ: AKBA) is poised to impact the landscape of renal therapeutics, particularly as it preps for its quarterly e…